TRDA icon

Entrada Therapeutics

111 hedge funds and large institutions have $290M invested in Entrada Therapeutics in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 42 reducing their positions, and 11 closing their positions.

Holders
111
Holders Change
+8
Holders Change %
+7.77%
% of All Funds
1.51%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
20
Increased
28
Reduced
42
Closed
11
Calls
$124K
Puts
$21K
Net Calls
+$103K
Net Calls Change
-$511K
Name Market Value Shares Shares
Change
Shares
Change %
CA
101
CoreCap Advisors
Michigan
$434 48 +48 New
HFS
102
Hughes Financial Services
Virginia
$429 49 +49 New
PFBT
103
Parkside Financial Bank & Trust
Missouri
$362 40 +40 New
FFO
104
Fortitude Family Office
Arizona
$334 37
AF
105
Allworth Financial
California
$323 36 +36 New
CCM
106
Coldstream Capital Management
Washington
$298 33 +33 New
CMBA
107
C.M. Bidwell & Associates
Hawaii
$262 29 -183 -86%
Nisa Investment Advisors
108
Nisa Investment Advisors
Missouri
$244 27 -100 -79%
RIL
109
Rothschild Investment LLC
Illinois
$181 20 +20 New
Amundi
110
Amundi
France
$96 12 -42 -78%
SS
111
SBI Securities
Japan
$9 1 +1 New
BCG
112
BayBridge Capital Group
California
-28,563 Closed
ECM
113
ExodusPoint Capital Management
New York
-16,453 Closed
SG Americas Securities
114
SG Americas Securities
New York
-14,036 Closed
Verition Fund Management
115
Verition Fund Management
Connecticut
-14,030 Closed
PP
116
PDT Partners
New York
-12,538 Closed
Millennium Management
117
Millennium Management
New York
-12,527 Closed
VEA
118
Virtus ETF Advisers
New York
-3,924 Closed
Osaic Holdings
119
Osaic Holdings
Arizona
-407 Closed
TWD
120
True Wealth Design
Ohio
-93 Closed
PA
121
Parallel Advisors
California
-16 Closed
EWA
122
EverSource Wealth Advisors
Alabama
-14 Closed
Simplex Trading
123
Simplex Trading
Illinois
CFGS
124
Concourse Financial Group Securities
Alabama